Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-134623
Filing Date
2021-11-04
Accepted
2021-11-04 21:00:33
Documents
1
Period of Report
2021-11-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2131859-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2131859-1_4seq1.xml 4 10994
  Complete submission text file 0001104659-21-134623.txt   13688
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Reporting) CIK: 0001425738 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40969 | Film No.: 211381952

Mailing Address ONE LETTERMAN DRIVE, BUILDING D SUITE D3-300 SAN FRANCISCO CA 94129
Business Address
Green Jeremy (Reporting) CIK: 0001650527 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40969 | Film No.: 211381951

Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Issuer) CIK: 0001689375 (see all company filings)

EIN.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address LETTERMAN DIGITAL ARTS CENTER ONE LETTERMAN DRIVE, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address LETTERMAN DIGITAL ARTS CENTER ONE LETTERMAN DRIVE, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Biopharma Investments III, L.P. (Reporting) CIK: 0001838746 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40969 | Film No.: 211381950